A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women

International Journal of Cancer

Volumn 92, Issue 6, 2001, Pages 888-892

  Lukanova, Annekatrin ^a   Toniolo, Paolo ^b   Akhmedkhanov, Arslan ^b   Biessy, Carine ^a   Haley, Nancy J ^c   Shore, Roy E ^b   Riboli, Elio ^a   Rinaldi, Sabina ^a   Kaaks, Rudolf ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Insurance Testing Laboratory   (United States)

Author keywords

Cohort studies; Cotinine; Insulin like growth factor I; Lung cancer

Indexed keywords

COTININE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD LEVEL; BREAST CANCER; CANCER GROWTH; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MITOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER;

ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LUNG NEOPLASMS; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0035876947     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1265     Document Type: Article

References (35)

1. Jones JI, Gemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
2. Baxter RC, Turtle JR. Regulation of hepatic growth hormone receptors by insulin. Biochem Biophys Res Commun 1978;84:350-7.
3. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994;15:80-101.
4. Clemmons DR. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 1997;8: 45-62.
5. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 1996;28:619-37.
6. Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 1997;272:12181-8.
7. Werner H, Leroith D. The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 1996;68:183-223.
8. Macaulay VM, Everard MJ, Teale JD, Trott PA, Van Wyk JJ, Smith IE, et al. Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells. Cancer Res 1990;50:2511-7.
9. Nakanishi Y, Mulshine JL, Kasprzyk PG, Natale RB, Maneckjee R, Avis I, et al. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest 1988;82:354-9.
10. Leroith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995;16:143-63.
11. Werner H, Karnieli E, Rauscher FJ, Leroith D. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 1996;93:8318-23.
12. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995;377:646-9.
13. Stiles AD, D'Ercole AJ. The insulin-like growth factors and the lung, Am J Respir Cell Mol Biol 1990;3:93-100.
14. Quinn KA, Treston AM, Unsworth EJ, Miller MJ, Vos M, Grimley C, et al. Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 1996;271:11477-83.
15. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 1999;91:151-6.
16. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000;92:1592-600.
17. Toniolo P, Bruning P, Akmedhanov A, Bonfrer JMG, Koenig KL, Lukanova A, et al. Serum insulin-like growth factor-I and breast cancer. Int J Cancer 2000;88:828-32.
18. Haley NJ, Axelrad CM, Tilton KA. Validation of self-reported smoking behavior: biochemical analyses of cotinine and thiocyanate. Am J Public Health 1983;73:1204-7.
19. SAS Institute. SAS/STATR User's guide version 6. SAS Manual 4(6). Cary, NC: SAS Institute Inc., 1990.
20. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, et al. Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) 1994;41:351-7.
21. Goodman GD, Barrett CE. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 1997;145:970-6.
22. Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SW. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vase Biol 1998;18:277-82.
23. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Mantzoros C. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. J Clin Oncol 1999;17:813-7.
24. Abate N. Insulin resistance and obesity. The role of fat distribution pattern. Diabetes Care 1996;19:292-4.
25. Kabat GC, Wynder EL. Body mass index and lung cancer risk. Am J Epidemiol 1992;135:769-74.
26. Knekt P, Heliovaara M, Rissanen A, Aromaa A, Seppanen R, Teppo L, et al. Leanness and lung-cancer risk. Int J Cancer 1991;49:208-13.
27. Rauscher GH, Mayne ST, Janerich DT. Relation between body mass index and lung cancer risk in men and women never and former smokers. Am J Epidemiol 2000;152:506-13.
28. Drinkard CR, Sellers TA, Potter JD, Zheng W, Bostick RM, Nelson CL, et al. Association of body mass index and body fat distribution with risk of lung cancer in older women. Am J Epidemiol 1995;142: 600-7.
29. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:164-79.
30. Fisher WE, Boros LG, Schirmer WJ. Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res 1996;63:310-3.
31. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 1997; 21:355-9.
32. Nyomba BL, Berard L, Murphy LJ. Free insulin-like growth factor 1 (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity. J Clin Endocrinol Metab 1997;82:2177-81.
33. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-6.
34. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563-6.
35. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999;91:620-5.